Form N-CSRS Virtus Convertible & For: Jul 31
http://archive.fast-edgar.com/20261008/AQ22QG2GZC2RPZZZ272M2ZYLKDOAYZ22Z282
Filed on: October 8, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SK hynix Announces 3Q26 Financial Results
- Arthur J. Gallagher & Co. Announces Regular Fourth Quarter Dividend
- Astellas and Audax Biosciences Enter Exclusive Option and License Agreement for DAX-044, a Novel Immune-Targeted IL-12 Antibody-Cytokine Fusion for Immuno-Oncology
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share